THOMAS A. BAN

Books Edited/Co-edited

 

  1. Lehmann HE, Ban TA. The Butyrophenones in Psychiatry.  Montreal: Quebec

            Psychopharmacological  Research Association; 1964.

  1. Lehmann HE, Berthiaume M, Ban TA. Trimipramine, a New Antidepressant. Montreal:  Quebec Psychopharmacological Research Association; 1965.
  2. Lehmann HE, Ban TA. Toxicity and Adverse Reaction Studies with Neuroleptics and Antidepressants. Montreal: Quebec Psychopharmacological Research Association; 1968.
  3. Lehmann HE, Ban TA. The Thioxanthenes. Basel: Karger; 1969.
  4. Ban TA, Boissier JA, Gessa, GJ,  Heimann H, Hollister,  Lehmann  HE, Munkvad J, Steinberg H, Sulser F,   Sundvall A, Vinar O.  Pssychopharmacology, Sexual Disorders, and Dug Abuse. Amsterdam: North Holland; 1973.
  5. Ban TA, Silvestrini B.  Trazodone.  Basel: Karger; 1974.
  6. Ban TA, Freyhan F. Drug Treatment of Sexual Dysfunction. Basel: Karger; 1980.
  7. Prevention and Treatment of Depression Ban TA, Gonzalez R, Jablensky AS, Sartorius N, Vartanian F. Prevention and Treatment of Depression. Baltimore: University Park Press; 1981.
  8. Guy W, Ban TA. The AMDP-System. Manual for the Assessment and Documentation of Psychopathology (translated and edited). Berlin: Springer; 1982.
  9. Ban TA. Depression and Somatic Illness. Morristown:  Pharmalibri; 1984.
  10. Baan TA. Amoxapine and Psychotic Depression. Memphis: The Journal of Clinical Psychiatry Monograph Series (Volume 3, Number 1); 1985.
  11. Guy W, Ban TA. The AGP System. Manual for the Documentation of Psychopathology in Gerontopsychiatry (translated and edited).Hejdelberg: Springer; 1985.
  12. Sartorius N, Ban TA. Assessment of Depression. Heidelberg: Springer; 1986.
  13. McGuigan J, Ban TA. Critical Issues in Psychology, Psychiatry and Physiology. A Memorial to W. Horsley Gantt. New York:  Gordon and Breach; 1987.
  14. Ban TA, Hippius H. Thirty Years CINP. Berlin: Springer; 1988.
  15. Ban TA, Lehmann HE. Diagnosis and Treatment of Old Age Dementias. Basel: Karger;  1989.
  16. Aguglia E, Ban TA. Functional Psychoses Today. Rome: John Libbey; 1991.
  17. Ban TA, Hippius H. Psychopharmacology in Perspective. A Personal Account by the      Founders of the Collegium Internationale  Neuro-Psychopharmacologicum. Berlin: Springer; 1992.
  18. Ban TA, Hippius H. Towards CINP. From the Paris Colloquium to the Milan Symposium (T. A. Ban, H. Hippius),  Brentwood: JM Productions; 1994.
  19. Gaszner P, Ban TA. Composite Diagnostic Evaluation System in Psychiatry. Budapest: Animula; 1995.
  20. Ban TA, Ray O. A History of the CINP. Brentwood: J. M. Productions; 1996.
  21. Ban TA, Healy D, Shorter E. The Rise of Psychopharmacology and The Story of CINP. Budapest: Animula; 1998.
  22. Ban TA, Healy D, Shorter E. The Triumph of Psychopharmacology and The Story of CINP. Budapest: Animula; 2000.
  23. Ban TA, Beckmann H, Ray O. CINP International Photo Archives in Neuropsychopharmacology. Budapest: Animula;   2000.
  24. Faludi G, Ban TA. Gaszner Peter Valogatott Tanulmanyai. Budapest: Animula;  2001.
  25. Ban TA, Healy D, Shorter E. From Psychopharmacology to Neuropsychopharmacology and the Story of CINP. Budapest: Animula; 2002.
  26. Ban TA. Selected Writings of Joel Elkes. Budapest: Animula; 2002.
  27. Ray O, Ban TA. An Early Attempt to Foster Neuroscience Gobalization An Autobiography by Erminio Costa. Nashville:  The Good Life Press; 2003.
  28. Ban TA, Healy D, Shorter E. Reflections on Twentieth-Century Psychopharmacology. Budapest: Animula; 2004.
  29. Ban TA, Ucha Udabe R. The Neurotransmitter Era in Neuropsychopharmacology. Buenos Aires.  Editorial Polemos; 2006.
  30. Ban TA. An Oral History of Neuropsychopharmacology. Volume 1. Starting Up. (Volume editor: Edward Shorter). Brentwood: American College of Neuropsychopharmacology;, 2011.
  31.  Ban TA. An Oral History of Neuropsychopharmacology. Volume 2. Neurophysiology. (Volume editor: Max Fink). Brentwood: American College of Neuropsychopharmacology; 2011.
  32. Ban TA. An Oral History of Neuropsychopharmacology. Volume 3. Neuropharmacology. (Volume editor: Fridolin Sulser). Brentwood: American College of Neuropsychopharmacology; 2011.
  33. Ban TA. An Oral History of Neuropsychopharmacology. Volume 4 Psychopharmacology. (Volume editor: Jerome Levine). Brentwood: American College of Neuropsychopharmacology; 2011.
  34. Ban TA. An Oral History of Neuropsychopharmacology. Volume 5. Neuropsychopharmacology. (Volume editor: SamuelGeshon). Brentwood: American College of Neuropsychopharmacology; 2011.
  35. Ban TA. An Oral History of Neuropsychopharmacology. Volume 6. Addictions. (Volume editor: Herbert Kleber). Brentwood: American College of Neuropsychopharmacology; 2011.
  36. Ban TA. An Oral History of Neuropsychopharmacology. Volume 7. Special Areas. (Volume editor: Barry Blackwell). Brentwood: American College of Neuropsychopharmacology; 2011.
  37. Ban TA. An Oral History of Neuropsychopharmacology. Volume 8. Diverse Topics. (Volume editor: Carl Salzman). Brentwood: American College of Neuropsychopharmacology; 2011.
  38. Ban TA. An Oral History of Neuropsychopharmacology. Volume 9. Update. (Volume editor: Barry Blackwell). Brentwood: American College of Neuropsychopharmacology; 2011.
  39. Ban TA. An Oral History of Neuropsychopharmacology. Volume 10. The History of ACNP. (Volume editor: Martin M. Katz). Brentwood: American College of Neuropsychopharmacology; 2011
  40. Martin PR, Ban TA. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by Leo E. Hollister. INHN E-Books. February 6, 2014.

 

Thomas A.  Ban

June 9, 2016

 

Gin S. Malhi: A critical analysis of concepts in psychiatry.

Gin S.  Malhi and Erica Bell: Make News - Suicidal Behavior Disorder: A “Diagnosis” with Good Intentions

 

Hector Warnes’ comment

 

 

        I am most impressed by this paper that distinguishes the Suicidal Behavior Disorder (SBD) from non-suicidal self-injury (it maybe an overlap between the two) and outlines five proposed criteria for the former. The authors recognized that a person may take his/her life without being mentally ill and that there is an insidious process starting off with a previous suicidal attempt within the last 24 months. It is also accepted that the more suicidal attempts (even by overdose of pills) the likelihood increases that the NSSI (non suicidal self-injury) may end up dead.

        What is most original -- and I have encountered it -- is the fact that the future completed suicide may go unnoticed by anybody because the person does not explicitly mention it. There is an excellent table that includes the ideational phase that may be countered by rescue factors or volitional factors in a delicate equilibrium which may be followed by an intent and an attempt.

        Suicide, as the authors underline, consists of a biopsychological risk diathesis including brain states (its final outcome hangs on reappraisal of self, others and situational factors). There have been many post-mortem studies of the cerebrospinal fluid and the brain (Van Praag 1982). The person who is likely to commit suicide feels an "overwhelming sense of defeat and entrapment" before the final attempt. The intent is the determining factor and constitutes an inescapable and final intentional act.

        There are a significant number of patients (about 60%) who write messages before the attempted suicide. I have also seen over the years patients who regret having made a very serious attempt on their life (such as an attempt at hanging or shooting or drowning) in a moment of despair, drunken, transient hopeless, guilt and impulsivity. However, they are the exception. Most patients who wish to die, who repeat to themselves that life is not worth living, that they are a burden to their family, that they see no way out and they are contemplating or searching for a sure and definite method are most likely to be SBD. It adds to a sense of anhedonia, there is nothing that they can enjoy added to despondency, anorexia, loss of libido, loss of sleep and psychomotor retardation. A. Camus (1955), in “The Myth of Sysiphus,” offers us an extraordinary example of a man living in an existential void, carrying on a meaningless job and being absorbed by the absurdity of his life.

        A similar attempt to analyse the grave risk of suicide was published by M. Benoit (2002) who classifies the suicidal process in a long ideational phase filled with doubts and ambivalence, in laying out a plan, in making a decision and in choosing the day, the method and the circumstances of the final attempt (passage a l'acte) unless embarking on a successful therapy.

 

References:

 

Benoit M. Quels sont les symptomes a observer a chaque étape de la crise suicidaire? In: Fédération francaise de Psychiatrie. La crise suicidaire. Reconaitre et prendre en charge, Conférence de consensus, 19 et 20 Octobre 2000, John Libbey, Paris, 2002. 

Camus A. The Myth of Sisyphus and other Essays. New York, Alfred A. Knopf, 1955. 

Van Praag H. Depression, suicide and the metabolism of serotonin in the brain. J. Affect. Disorders. 1982; 4:275-90.

 

July 30, 2020